Developed & Manufactured by Biomedica

High quality ELISAs
Developed and manufactured by Biomedica

Featured Products & Promotions

Latest News
  • DKK-1 an immune-suppressive driver in breast cancer
    DKK-1 an immune-suppressive driver in breast cancer
    13 October, 2026
    A recent study published in Nature Communications demonstrates that Dickkopf-1 (DKK-1) has a broader role in breast cancer that extends beyond its function as a bone-related biomarker. The publication “Stroma-derived Dickkopf-1 contributes to the suppression of NK cell cytotoxicity in breast cancer,” reports that DKK-1 produced by the tumor stroma can suppress natural killer (NK) [...]
  • OPG and RANKL in Breast Cancer Research
    OPG and RANKL in Breast Cancer Research
    6 October, 2026
    Breast Cancer Awareness Month -  OPG and RANKL Research October marks Breast Cancer Awareness Month, a time to raise awareness and highlight scientific advances that deepen our understanding of breast cancer progression. Although early detection and treatment remain central to improving outcomes, ongoing research continues to uncover the biological pathways that influence how breast cancer [...]
  • Improving risk stratification in male haemodialysis patients using LRG
    Improving risk stratification in male haemodialysis patients using LRG
    29 September, 2026
    Leucine-rich alpha-2-glycoprotein  (LRG or also used as a synonym LRG1) is a matricellular protein that has been recognized for its role in inflammation, fibrosis, and cardiovascular disease (1). In renal disease, inflammation and vascular complications are key drivers of progression and poor outcomes. For patients with end-stage renal disease undergoing maintenance hemodialysis, traditional risk factors [...]
More News
Events
  • Biomedica at Osteologie in Salzburg
    19 June, 2023
    Biomedica features FGF23 ELISA - intact and C-terminal - assays Meet us at the OSTEOLOGIE Conference taking place from 22-24 June 2023 in Salzburg, Austria! We will exhibit at booth # 36 introducing our novel biomarker ELISA assays to investigate bone and cancer induced bone diseases (e.g. Periostin, Semaphorin 4D, LRG, and others). Our focus [...]
  • Biomedica @ Osteologie 2020 in Salzburg
    17 February, 2020
    Meet us at the Osteologie 2020, hosted by the Deutsche Gesellschaft für Endokrinologie and the Österreichische Gesellschaft für Knochen- und Mineralstoffwechsel, taking place from 12-14 March 2020 in Salzburg, Austria! We will exhibit together with our partners Fianostics & TAmiRNA at booth #1. Moreover,  we will present out new VEGF-A ELISA at our poster "Novel VEGF-A ELISA [...]
  • Meet Biomedica at ASN Kidney Week
    7 November, 2019
    Meet us during ASN Kidney Week taking place from November 5-10 2019 in Washington, DC at booth no. 2005 Hosted by the American Society of Nephrology it’s the world’s premier nephrology meeting with more than 13,000 kidney specialists from across the globe. It provides participants with exciting and challenging opportunities to exchange knowledge, learn about [...]
More Events